IGC Pharma, Inc. IGC
0.19 USD -0.01 (-3.58%)
At closeNov 3, 2026, 5:31 PM EST
0.19 +0.01 +3.23%
After hours · Nov 3, 5:31 PM ET
0.185 Day range 0.20
0.08 52-week range 0.40
- YTD
- -33.57%
- 1 year
- -53.50%
Analyst view
Price target (mean) 3.75 +1916.1% upside
Now 0.186
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.03 | -0.03 – -0.03 | -0.0465 | +35.5% | 204.00K | 0.0% | 2 |
| Next quarter | -0.03 | -0.03 – -0.03 | -0.0328 | +8.5% | 295.00K | 0.0% | 2 |
| Current year | -0.11 | -0.11 – -0.11 | -0.1641 | +33.0% | 1.18M | -12.0% | 1 |
| Next year | -0.12 | -0.12 – -0.12 | -0.11 | -9.1% | 1.35M | +14.2% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Sep 3, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jul 29, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jul 17, 2024 | Alliance Global Partners | Initiated | — | Buy |
| Jun 21, 2024 | Ascendiant Capital | Reiterated | Buy | Buy |